Dave Toole - Lifevantage Independent Director

LFVN Stock  USD 6.19  0.05  0.80%   

Director

Mr. Dave Toole is Independent Director of the Company. Mr. Toole brings over 35 years of experience as a supply chain digital media and video expert and was the chief executive officer of MediaMobz a private company that enables brands to increase their capacity to create video centric digital media that drives business results since 2008. Mr. Toole is also currently the chief executive officer of Outhink Media an emerging media incubator which position he has held since 2001. Prior to Outhink Media Mr. Toole spent 21 years at GaSonics International a semiconductor capital equipment company where he worked in various positions including as chief executive officer from 1993 to 2001. As chief executive officer at GaSonics Mr. Toole led the company initial public offering in 1994 and the sale of the company to Novellus Systems in 2001. Mr. Toole began his career at Advance Micro Devices a manufacturer of early computer chips where he was a production supervisor from 1976 to 1979 since 2016.
Age 59
Tenure 8 years
Phone801 432 9000
Webhttps://www.lifevantage.com
Toole received his Bachelor of Arts degree in Business from the University of California, Santa Barbara.

Lifevantage Management Efficiency

The company has return on total asset (ROA) of 0.0392 % which means that it generated a profit of $0.0392 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1 %, meaning that it created $0.1 on every $100 dollars invested by stockholders. Lifevantage's management efficiency ratios could be used to measure how well Lifevantage manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 13.09 M in liabilities with Debt to Equity (D/E) ratio of 0.5, which is about average as compared to similar companies. Lifevantage has a current ratio of 1.79, which is within standard range for the sector. Debt can assist Lifevantage until it has trouble settling it off, either with new capital or with free cash flow. So, Lifevantage's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Lifevantage sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Lifevantage to invest in growth at high rates of return. When we think about Lifevantage's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Jeffrey WatkinsNatures Sunshine Products
53
Andrew WoeberCentral Garden Pet
49
Christopher TeetsNatures Sunshine Products
44
Peter StanleyJ J Snack
75
Michael EdwardsCentral Garden Pet
57
Daniel DwyerCoffee Holding Co
58
Kathryn BoorSeneca Foods Corp
59
Peter CallSeneca Foods Corp
61
John BalousekCentral Garden Pet
72
Michael EdwardsCentral Garden Pet
57
Gregory ScottBridgford Foods
61
Arthur BaerSeneca Foods Corp
68
Susan StuartSeneca Foods Corp
62
Gregory FlackAryzta AG PK
53
Travis RobbinsBridgford Foods
N/A
Rebecca SteinfortNatures Sunshine Products
45
Todd AndrewsBridgford Foods
52
George SentLifeway Foods
46
Thomas PaulsonSeneca Foods Corp
61
John HansonCentral Garden Pet
58
Mariano LozanoLifeway Foods
47
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. Lifevantage operates under Packaged Foods classification in the United States and is traded on NASDAQ Exchange. It employs 259 people. Lifevantage (LFVN) is traded on NASDAQ Exchange in USA. It is located in 3300 N. Triumph Blvd, Lehi, UT, United States, 84043 and employs 248 people. Lifevantage is listed under Pharmaceutical Products category by Fama And French industry classification.

Management Performance

Lifevantage Leadership Team

Elected by the shareholders, the Lifevantage's board of directors comprises two types of representatives: Lifevantage inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lifevantage. The board's role is to monitor Lifevantage's management team and ensure that shareholders' interests are well served. Lifevantage's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lifevantage's outside directors are responsible for providing unbiased perspectives on the board's policies.
Carl Aure, Chief Officer
Justin Rose, Chief Sales Officer
Courtland Pearson, Senior Vice President of International
Garry Mauro, Independent Director
Michelle ObornVirchow, Vice President - Human Resources
Vinayak Hegde, Director
George Metzger, Independent Director
Calli Mott, Senior Experience
Chris Taylor, Director Communications
Darwin Lewis, Director
Gary Koos, Interim CFO
Raymond Greer, Director
Kevin McMurray, General Counsel
Richard Okumoto, Independent Director
Darren Jensen, CEO and President and Director
Dave Fleming, VP Sales
Ryan Thompson, Sr. VP of Sales
Steven Fife, CEO President
Julie Boyster, Chief Officer
Ryan Goodwin, Chief Marketing Officer
Kristen Cunningham, Chief Officer
David Manovich, Executive Vice Chairman
Dave Toole, Independent Director
Eric Marchant, Vice Compliance
Robert Urban, COO
David Toole, Independent Director
Alissa Neufeld, General Secretary
Charles Wach, COO
Eiichi Shiokawa, Managing Japan
Mark Jaggi, CFO and Treasurer
Matthew Cooley, Chief Officer
Michael Beindorff, Independent Director

Lifevantage Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Lifevantage a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Lifevantage offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lifevantage's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lifevantage Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lifevantage Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifevantage. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Lifevantage Stock, please use our How to Invest in Lifevantage guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Lifevantage Stock analysis

When running Lifevantage's price analysis, check to measure Lifevantage's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifevantage is operating at the current time. Most of Lifevantage's value examination focuses on studying past and present price action to predict the probability of Lifevantage's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifevantage's price. Additionally, you may evaluate how the addition of Lifevantage to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Commodity Directory
Find actively traded commodities issued by global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamental Analysis
View fundamental data based on most recent published financial statements
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is Lifevantage's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lifevantage. If investors know Lifevantage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lifevantage listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lifevantage is measured differently than its book value, which is the value of Lifevantage that is recorded on the company's balance sheet. Investors also form their own opinion of Lifevantage's value that differs from its market value or its book value, called intrinsic value, which is Lifevantage's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lifevantage's market value can be influenced by many factors that don't directly affect Lifevantage's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lifevantage's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lifevantage is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lifevantage's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.